BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Genstruct Applying Epistemics Approach To 'Molecular World' (BioWorld Today)
News | 01. 20. 2004
Genstruct Inc. is approaching a drug discovery obstacle in a thoroughly modern way, that is, with what it calls “logical models” of biological systems designed to uncover and define compound mechanisms of action and disease mechanisms.
